Literature DB >> 29034538

Association of insomnia severity with well-being, quality of life and health care costs: A cross-sectional study in older adults with chronic pain (PainS65+).

E Dragioti1, L Bernfort2, B Larsson1, B Gerdle1, L Å Levin2.   

Abstract

BACKGROUND: Insomnia is one of the most common complaints in chronic pain. This study aimed to evaluate the association of insomnia with well-being, quality of life and health care costs.
METHODS: The sample included 2790 older individuals (median age = 76; interquartile range [IQR] = 70-82) with chronic pain. The participants completed a postal survey assessing basic demographic data, pain intensity and frequency, height, weight, comorbidities, general well-being, quality of life and the insomnia severity index (ISI). Data on health care costs were calculated as costs per year (€ prices) and measured in terms of outpatient and inpatient care, pain drugs, total drugs and total health care costs.
RESULTS: The overall fraction of clinical insomnia was 24.6% (moderate clinical insomnia: 21.9% [95% CI: 18.8-23.3]; severe clinical insomnia: 2.7% [95% CI: 1.6-3.2]). Persons who reported clinical insomnia were more likely to experience pain more frequently with higher pain intensity compared to those reported no clinically significant insomnia. Mean total health care costs were € 8469 (95% CI: €4029-€14,271) for persons with severe insomnia compared with € 4345 (95% CI: €4033-€4694) for persons with no clinically significant insomnia. An association between severe insomnia, well-being, quality of life, outpatient care, total drugs costs and total health care costs remained after controlling for age, sex, pain intensity, frequency, body mass index and comorbidities using linear regression models.
CONCLUSIONS: Our results determine an independent association of insomnia with low health-related quality of life and increased health care costs in older adults with chronic pain. SIGNIFICANCE: The concurrence and the severity of insomnia among older adults with chronic pain were associated with decreased well-being and quality of life, and increased health care costs to society.
© 2017 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2017        PMID: 29034538     DOI: 10.1002/ejp.1130

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  7 in total

1.  Economic aspects of insomnia medication treatment among Medicare beneficiaries.

Authors:  Emerson M Wickwire; Aparna Vadlamani; Sarah E Tom; Abree M Johnson; Steven M Scharf; Jennifer S Albrecht
Journal:  Sleep       Date:  2020-01-13       Impact factor: 5.849

2.  Untreated insomnia increases all-cause health care utilization and costs among Medicare beneficiaries.

Authors:  Emerson M Wickwire; Sarah E Tom; Steven M Scharf; Aparna Vadlamani; Ilynn G Bulatao; Jennifer S Albrecht
Journal:  Sleep       Date:  2019-04-01       Impact factor: 5.849

3.  Chronic Pain, Sleep, and Cognition in Older Adults With Insomnia: A Daily Multilevel Analysis.

Authors:  Ashley F Curtis; Jacob M Williams; Karin J M McCoy; Christina S McCrae
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

4.  Insomnia in Older Adults.

Authors:  Vivian Nguyen; Tessy George; Glenna S Brewster
Journal:  Curr Geriatr Rep       Date:  2019-10-22

5.  Positive psychological well-being predicts lower severe pain in the general population: a 2-year follow-up study of the SwePain cohort.

Authors:  Britt Larsson; Elena Dragioti; Björn Gerdle; Jonas Björk
Journal:  Ann Gen Psychiatry       Date:  2019-05-31       Impact factor: 3.455

6.  Self-reported poor sleep on multiple dimensions is associated with higher total health care costs in older men.

Authors:  John T Schousboe; Allyson M Kats; Katie L Stone; Lisa Langsetmo; Tien N Vo; Terri L Blackwell; Daniel J Buysse; Sonia Ancoli-Israel; Kristine E Ensrud
Journal:  Sleep       Date:  2020-10-13       Impact factor: 5.849

7.  Factors Associated with Life Satisfaction in Older Adults with Chronic Pain (PainS65+).

Authors:  Huan-Ji Dong; Britt Larsson; Elena Dragioti; Lars Bernfort; Lars-Åke Levin; Björn Gerdle
Journal:  J Pain Res       Date:  2020-03-05       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.